Areas of Focus
- Tumor Systems Biology and Molecular Biology
- Metabolomics and Multi-Omics with Machine Learning for Cancer Detection
Work Experience
- 2016-2019: Assistant Researcher, First Medical Center Oncology Laboratory, PLA General Hospital
- 2019-2022: Postdoctoral Fellow, Department of Genetics, Peking University Health Science Center
- 2022-present: Assistant Professor, Associate Researcher, Doctoral Supervisor, Institute of Systems Biomedicine, Peking University
Academic Background & Achievements
- 2008-2013: Bachelor of Medicine, Peking University
- 2013-2016: PhD in Pathology, Peking University
- Published multiple SCI papers as first author
- Holds two national patents
Publications
- Lung cancer scRNA-seq and lipidomics reveal aberrant lipid metabolism for early-stage diagnosis, Guangxi Wang et al., 2022
- Metabolic detection and systems analyses of pancreatic ductal adenocarcinoma through machine learning, lipidomics, and multi-omics, Guangxi Wang et al., 2021
- PTEN regulates RPA1 and protects DNA replication forks, Guangxi Wang et al., 2015
- Metabolic detection of malignant brain gliomas through plasma lipidomic analysis and support vector machine-based machine learning, Guangxi Wang et al., 2022
- RPA1 controls chromatin architecture and maintains lipid metabolic homeostasis, Guangxi Wang et al., 2022
- Identification of diagnostic markers and lipid dysregulation in oesophageal squamous cell carcinoma through lipidomic analysis and machine learning, Guangxi Wang et al., 2021
Awards
- 2016: Peking University May Fourth Medal
- 2016: Beijing Outstanding Graduate
- 2017: Second Prize of Chinese Medical Science and Technology (Third Contributor)
- 2020: Peking University Health Science Center Education Award
- 2021: Peking University Outstanding Union Activist
- 2021: Peking University Health Science Center Outstanding Communist Party Member
- 2022: Peking University Health Science Center Young Talent Award
- 2022: Peking University Outstanding Postdoctoral Fellow